Home LiteratureArticle Details
PMID: 11567048 Published · ppublish English Clinical Trial Controlled Clinical Trial Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Familial amyloid polyneuropathy: receptor for advanced glycation end products-dependent triggering of neuronal inflammatory and apoptotic pathways.

Sousa MM, Du Yan S, Fernandes R, Guimaraes A, Stern D, Saraiva MJ

Abstract

Familial amyloid polyneuropathy (FAP) is a neurodegenerative disorder associated with extracellular deposition of mutant transthyretin (TTR) amyloid fibrils, particularly in the peripheral nervous system. We have hypothesized that binding of TTR fibrils to the receptor for advanced glycation end products (RAGE) on critical cellular targets is associated with a destructive stress response underlying peripheral nerve dysfunction. Analysis of nerve biopsy samples from patients with FAP (n = 16) at different stages of disease (0-3), compared with age-matched controls (n = 4), by semiquantitative immunohistology and in situ hybridization showed increased levels of RAGE, beginning at the earliest stages of the disease (FAP 0; p < 0.02) and especially localized in axons. Upregulation of proinflammatory cytokines (tumor necrosis factor-alpha and interleukin-1beta) (approximately threefold; p < 0.02) and the inducible form of nitric oxide synthase (iNOS) ( approximately 2.5-fold; p < 0.04) was also observed in a distribution overlapping RAGE expression. Tyrosine nitration and increased activated caspase-3 in axons from FAP patients (p < 0.03) were apparent. Although these data suggest the presence of ongoing neuronal stress, there was no upregulation of neurotrophins (nerve growth factor and neurotrophin-3) in FAP nerves. Studies on cultured neuronal-like, Schwann, and endothelial cells incubated with TTR fibrils displayed RAGE-dependent expression of cytokines and iNOS at early times (6 and 12 hr, respectively), followed by later (24 hr) activation of caspase-3 and DNA fragmentation. We propose that the interaction of TTR fibrils with RAGE may contribute to cellular stress and toxicity in FAP. Furthermore, there is an apparent lack of responsiveness of Schwann cells in FAP nerve to provide neurotrophic factors.

MeSH Terms
Adolescent Adult Amyloid Neuropathies/metabolism,pathology Apoptosis Biopsy Cells, Cultured Cytokines/biosynthesis Humans Inflammation/metabolism,pathology Macromolecular Substances Middle Aged Nerve Growth Factors/biosynthesis,genetics Neurons/metabolism,pathology Nitric Oxide Synthase/metabolism Nitric Oxide Synthase Type II Oxidative Stress Prealbumin/genetics Protein Binding RNA, Messenger/analysis,biosynthesis Receptor for Advanced Glycation End Products Receptors, Immunologic/metabolism Schwann Cells/drug effects,metabolism,pathology Signal Transduction Sural Nerve/metabolism,pathology
Chemicals
Cytokines Macromolecular Substances Nerve Growth Factors Prealbumin RNA, Messenger Receptor for Advanced Glycation End Products Receptors, Immunologic NOS2 protein, human Nitric Oxide Synthase Nitric Oxide Synthase Type II
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Sousa M M
Institute for Cellular and Molecular Biology, Columbia University, New York, New York 10032, USA.
Du Yan S
Fernandes R
Guimaraes A
Stern D
Saraiva M J
References (40)
40 references, click to expand
  1. Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. I. Interstitial changes.
    Brain. 1971;94(2):199-206 PMID: 4328329
  2. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.
    Nature. 2000 Dec 21-28;408(6815):979-82 PMID: 11140685
  3. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis.
    Circ Res. 1999 Mar 19;84(5):489-97 PMID: 10082470
  4. Widespread peroxynitrite-mediated damage in Alzheimer's disease.
    J Neurosci. 1997 Apr 15;17(8):2653-7 PMID: 9092586
  5. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse.
    Nature. 1999 Jul 8;400(6740):173-7 PMID: 10408445
  6. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control.
    Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10057-62 PMID: 9294162
  7. Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis.
    Nat Med. 2000 Jun;6(6):643-51 PMID: 10835680
  8. 'In vitro' amyloid fibril formation from transthyretin: the influence of ions and the amyloidogenicity of TTR variants.
    Biochim Biophys Acta. 1996 May 24;1316(1):35-42 PMID: 8634341
  9. Amyloid fibril toxicity in Alzheimer's disease and diabetes.
    Ann N Y Acad Sci. 1996 Jan 17;777:89-95 PMID: 8624132
  10. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.
    Cell. 1999 Jun 25;97(7):889-901 PMID: 10399917
  11. Unraveling peroxynitrite formation in biological systems.
    Free Radic Biol Med. 2001 Mar 1;30(5):463-88 PMID: 11182518
  12. beta-Amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis.
    J Neurosci. 2001 Feb 15;21(4):1179-88 PMID: 11160388
  13. Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.
    J Biol Chem. 1999 Sep 3;274(36):25945-52 PMID: 10464339
  14. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease.
    Nature. 2000 Dec 21-28;408(6815):982-5 PMID: 11140686
  15. The biochemistry of apoptosis.
    Nature. 2000 Oct 12;407(6805):770-6 PMID: 11048727
  16. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins.
    Neuron. 1995 Nov;15(5):1203-18 PMID: 7576662
  17. Transthyretin mutations in hyperthyroxinemia and amyloid diseases.
    Hum Mutat. 2001 Jun;17(6):493-503 PMID: 11385707
  18. Schwann cells, neurotrophic factors, and peripheral nerve regeneration.
    Microsurgery. 1998;18(7):397-405 PMID: 9880154
  19. Familial amyloid polyneuropathy: an electron microscope study of the peripheral nerve in five cases. II. Nerve fibre changes.
    Brain. 1971;94(2):207-12 PMID: 4328330
  20. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease.
    Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3270-4 PMID: 8159737
  21. Cell mediators of inflammation in the Alzheimer disease brain.
    Alzheimer Dis Assoc Disord. 2000;14 Suppl 1:S47-53 PMID: 10850730
  22. Length-dependent degeneration of fibers in Portuguese amyloid polyneuropathy: a clinicopathologic study.
    Neurology. 1984 Aug;34(8):1025-32 PMID: 6087202
  23. Interaction of the receptor for advanced glycation end products (RAGE) with transthyretin triggers nuclear transcription factor kB (NF-kB) activation.
    Lab Invest. 2000 Jul;80(7):1101-10 PMID: 10908156
  24. Cellular cofactors for amyloid beta-peptide-induced cell stress. Moving from cell culture to in vivo.
    Am J Pathol. 1999 Nov;155(5):1403-11 PMID: 10550293
  25. Hyperhomocysteinemia enhances vascular inflammation and accelerates atherosclerosis in a murine model.
    J Clin Invest. 2001 Mar;107(6):675-83 PMID: 11254667
  26. Biochemical marker in familial amyloidotic polyneuropathy, Portuguese type. Family studies on the transthyretin (prealbumin)-methionine-30 variant.
    J Clin Invest. 1985 Dec;76(6):2171-7 PMID: 3908483
  27. Thyroxine binding to transthyretin Met 119. Comparative studies of different heterozygotic carriers and structural analysis.
    Endocrine. 1997 Jun;6(3):309-15 PMID: 9368688
  28. Amyloid-beta aggregation: selective inhibition of aggregation in mixtures of amyloid with different chain lengths.
    Biophys J. 1994 Sep;67(3):1216-28 PMID: 7811936
  29. Amyloid fibril protein in familial amyloidotic polyneuropathy, Portuguese type. Definition of molecular abnormality in transthyretin (prealbumin).
    J Clin Invest. 1984 Jul;74(1):104-19 PMID: 6736244
  30. Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models.
    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3228-33 PMID: 10077666
  31. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease.
    Nature. 1996 Aug 22;382(6593):685-91 PMID: 8751438
  32. NO synthase and NO-dependent signal pathways in brain aging and neurodegenerative disorders: the role of oxidant/antioxidant balance.
    Neurochem Res. 2000 Oct;25(9-10):1315-41 PMID: 11059804
  33. The receptor for advanced glycation end products (RAGE) is a cellular binding site for amphoterin. Mediation of neurite outgrowth and co-expression of rage and amphoterin in the developing nervous system.
    J Biol Chem. 1995 Oct 27;270(43):25752-61 PMID: 7592757
  34. Toxicity of various amyloid beta peptide species in cultured human blood-brain barrier endothelial cells: increased toxicity of dutch-type mutant.
    J Neurosci Res. 2000 Jun 15;60(6):804-10 PMID: 10861793
  35. Vulnerability of nerve fibres to ischaemia. A quantitative light and electron microscope study.
    Brain. 1991 Aug;114 ( Pt 4):1929-42 PMID: 1884186
  36. Glial cytokines in Alzheimer's disease: review and pathogenic implications.
    Hum Pathol. 1995 Aug;26(8):816-23 PMID: 7635444
  37. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor.
    Exp Neurol. 1999 Nov;160(1):289-99 PMID: 10630213
  38. Morphology and toxicity of Abeta-(1-42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer's disease.
    J Biol Chem. 1996 Aug 23;271(34):20631-5 PMID: 8702810
  39. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues.
    Am J Pathol. 1993 Dec;143(6):1699-712 PMID: 8256857
  40. The biology of the receptor for advanced glycation end products and its ligands.
    Biochim Biophys Acta. 2000 Dec 20;1498(2-3):99-111 PMID: 11108954
Article Info
Journal
The Journal of neuroscience : the official journal of the Society for Neuroscience
Abbr.
J Neurosci
ISSN
1529-2401
Published
2001-10-01
Pages
7576-86
Language
English
Region
United States
NLM ID
8102140
PMCID
PMC6762914
Subset
IM
Grants
NIA NIH HHS · AG16223 · United States
NIA NIH HHS · AG17490 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]